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Background:  Atrial fibrillation (AF) is common in diastolic heart failure (DHF). We hypothesized that AF may adversely impact exercise capacity in 
DHF. The Heart Failure Clinical Research Network has completed the RELAX trial: a multicenter randomized trial testing the impact of sildenafil® on 
peak VO2 in DHF.
methods: RELAX enrolled 216 DHF patients: 79 (37%) had AF, 124 (57%) were in sinus rhythm (SR), 13 were in other rhythms. Participants 
underwent a baseline cardiopulmonary exercise test (CPXT), echo, biomarker and rhythm status assessment prior to randomization.
results: See table. DHF patients with AF were older than those in SR but had similar symptom severity (NYHA class), co-morbidities and renal 
function. Despite comparable LV dimensions and LV mass index, AF was associated with worse systolic (lower EF and cardiac index) and diastolic 
(shorter deceleration time, higher right atrial and pulmonary artery systolic pressures, larger left atrial volume index) function compared to SR, 
though E/e’ was similar between groups. AF patients also had more severe neurohumoral activation. Peak VO2 was significantly reduced in AF, 
despite similar rest and peak heart rates and beta-blocker use (80% AF vs 73% SR, p=0.30) to SR patients. AF was associated with reduced peak 
VO2 even after adjustment for age and sex (p=0.04).
conclusion: AF identifies a DHF cohort with more advanced disease and significantly reduced exercise capacity. Whether AF is a marker or 
mediator of DHF progression warrants further investigation.
